Washington University

In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 6, 2026), Washington University reported 2 stock positions worth $160.2 million. Its top holding was Nu Holdings Ltd./Cayman Isl-A (NU) at 94.8% of the portfolio, followed by Maze Therapeutics (MAZE, 5.2%). Compared with Q4 2025, it sold out of 3. The biggest sale was an exit from Moderna (MRNA).

Most Recent 13F
Q2 2026
Location
ST LOUIS, MO
CIK
0000903603
Portfolio Value
$160.2M (Q1 2026)
SEC Filing
0000903603-26-000003 ↗ filed May 6, 2026

Holdings Value

0$100.0M$200.0M$300.0M Q1 2024: $270.4M Q1 2024 Q2 2024: $219.7M Q2 2024 Q3 2024: $154.2M Q3 2024 Q4 2024: $117.5M Q4 2024 Q1 2025: $110.8M Q1 2025 Q2 2025: $121.4M Q2 2025 Q3 2025: $178.5M Q3 2025 Q4 2025: $197.8M Q4 2025 Q1 2026: $160.2M $160.2M Q1 2026 Q2 2026: $264.8M Q2 2026

Holdings 2 stocks · $160.2M
NU Nu Holdings Ltd./Cayman Isl-A filed as NU HLDGS LTD 94.77% 10,566,927 $151.8M No change
MAZE Maze Therapeutics Inc. 5.23% 280,802 $8.4M No change

Portfolio Sells Q4 2025 → Q1 2026
MRNA Moderna Inc. Sold out 0.00% −2.24
RBRK Rubrik Inc. Class A Sold out 0.00% −1.95
FIG Figma Inc. Class A Sold out 0.00% −0.50

Portfolio Buys Q4 2025 → Q1 2026
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 3$264.8MNU, CBRS, RBRK
Q1 2026 2$160.2MNU, MAZE
Q4 2025 5$197.8MNU, MAZE, MRNA, RBRK, FIG
Q3 2025 3$178.5MNU, MAZE, MRNA
Q2 2025 4$121.4MNU, IOT, MRNA, PONY
Q1 2025 2$110.8MNU, MRNA
Q4 2024 3$117.5MNU, MRNA, ROAD
Q3 2024 4$154.2MNU, MRNA, UTI, CART
Q2 2024 3$219.7MNU, MRNA, UTI
Q1 2024 5$270.4MNU, UTI, CPNG, MRNA, U